If you have a certain kind of autoimmune condition, your doctor might suggest Simponi or Simponi Aria as a treatment option for you. The active ingredient in Simponi and Simponi Aria is golimumab. An ...
Simponi and Simponi Aria (golimumab) are brand-name drugs that’s prescribed for conditions such as psoriatic arthritis (PsA). As with other drugs, Simponi can cause side effects, such as skin rash and ...
Simponi and Simponi Aria (golimumab) can cause mild to serious side effects. A more common side effect includes upper respiratory infection. If side effects from the drug become difficult to tolerate, ...
Golimumab 50mg/4mL; soln for IV infusion after dilution; preservative- and latex-free. Simponi Aria (golimumab) Injection is a colorless to light yellow solution available in packs of 1 vial. Each ...
Centocor Ortho Biotech Inc. and Schering-Plough Corporation has announced that Health Canada has granted approval of Simponi (golimumab) as a once-monthly, subcutaneous therapy for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . Immgolis is the first interchangeable biosimilar to Simponi. It is approved for treatment of adults with ...
Janssen Biotech announced new five-year data from three pivotal Phase 3 studies evaluating Simponi (golimumab) 50mg administered subcutaneously once every four weeks in the treatment of moderately to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results